S. 2276: ETHIC Act

S. 2276 is a federal bill in the 119th Congress. Drug manufacturers trying to block lower-cost competitors currently can sue generic and biosimilar companies using dozens of related patents all at once, creating a dense legal barrier known as a patent thicket. Under this bill, brand-name drug companies… See its sponsors, how members voted, and a plain-English breakdown on PolityLens.